InvestorsHub Logo
Followers 0
Posts 878
Boards Moderated 0
Alias Born 12/11/2015

Re: None

Saturday, 11/17/2018 6:40:12 PM

Saturday, November 17, 2018 6:40:12 PM

Post# of 8110
It’s difficult to cull through everything however it began here;

GB Sciences, Inc. (GBLX)FORM 10-Q | Quarterly Report
Aug. 14, 2018 3:40 PM|About: GB Sciences, Inc. (GBLX)

ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds

During the three months ended June 30, 2018, the Company issued an aggregate of 17,434,636 shares of common stock, as follows:

? In order to encourage the exercise of the 8,000,000 warrants issued to investors in the private offering of convertible notes dated March 2017 and the 28,804,000 warrants issued to investors in the private offering of convertible notes dated July 2017, the Company effected a temporary decrease in the exercise price of the warrants from $0.60 and $0.65, respectively, to $0.30 and $0.325 per share. As a result of the price reduction, the Company issued 11,001,750 shares of its common stock and received net proceeds of approximately $3.5 million. In connection with the induced exercise of the warrants, the Company recorded an induced dividend of approximately $2.8

Call Damon Testaverde or Bill Hemming at Network1, they’ll have the current information as to the status of the reprising of the remaking warrants. I’ll continue looking for the SEC FILING in my spare time.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GBLX News